Business Insights
23andMe to Cut 40% of Workforce
23andMe, the DNA-testing company, announced a significant restructuring on November 11, 2024, involving a 40% reduction in its workforce—over 200 employees—and the discontinuation of its therapeutics division. This move aims to stabilize the company's financial position amid ongoing challenges. The therapeutics division, which was conducting